On how mammary gland reprogramming metalloproteinases couple form with function

Cold Spring Harbor Perspectives in Biology

Volumn 4, Issue 7, 2012, Pages 1-4

  Sloane, Bonnie F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE;

ANIMAL; ARTICLE; ENZYMOLOGY; METABOLISM; MOUSE; UDDER;

ANIMALS; MAMMARY GLANDS, ANIMAL; METALLOPROTEASES; MICE;

EID: 84863959010     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a013474     Document Type: Article

References (26)

1. Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A, Overall CM, Shapiro SD, Lopez-Otin C. 2003. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 35: 252-257.
2. Conus S, Simon HU. 2008. Cathepsins: Key modulators of cell death and inflammatory responses. Biochem Pharmacol 76: 1374-1382.
3. Curino AC, Engelholm LH, Yamada SS, Holmbeck K, Lund LR, Molinolo AA, Behrendt N, Nielsen BS, Bugge TH. 2005. Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy. J Cell Biol 169: 977-985.
4. Dalton WS. 2004. The proteasome. Semin Oncol 31: 3-9; discussion 33.
5. Decock J, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR, Ye S, Paridaens R. 2008. Plasma MMP1 and MMP8 expression in breast cancer: Protective role of MMP8 against lymph node metastasis. BMC Cancer 8: 77.
6. Dennemarker J, Lohmuller T, Muller S, Aguilar SV, Tobin DJ, Peters C, Reinheckel T. 2010. Impaired turnover of autophagolysosomes in cathepsin L deficiency. Biol Chem 391: 913-922.
7. Droga-Mazovec G, Bojic L, Petelin A, Ivanova S, Romih R, Repnik U, Salvesen GS, Stoka V, Turk V, Turk B. 2008. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J Biol Chem 283: 19140-19150.
8. Eskelinen EL, Saftig P. 2009. Autophagy: A lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 1793: 664-673.
9. Gutierrez-Fernandez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, Edwards DR, Holliday DL, Jones JL, Span PN, et al. 2008. Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res 68: 2755-2763.
10. Kawakubo T, Yasukochi A, Tsukuba T, Kadowaki T, Yamamoto K. 2008. Gene expression profiling of mammary glands of cathepsin E-deficient mice compared with wild-type littermates. Biochimie 90: 396-404.
11. Khokha R, Werb Z. 2011. Mammary gland reprogramming metalloproteinases couple form with function. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a004333.
12. Kjoller L, Engelholm LH, Hoyer-Hansen M, Dano K, Bugge TH, Behrendt N. 2004. uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV. Exp Cell Res 293: 106-116.
13. Kurschus FC, Bruno R, Fellows E, Falk CS, Jenne DE. 2005. Membrane receptors are not required to deliver granzyme B during killer cell attack. Blood 105: 2049-2058.
14. Lee SL, Huang PY, Roller P, Cho EG, Park D, Dickson RB. 2010. Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation. Mech Dev 127: 82-95.
15. List K, Haudenschild CC, Szabo R, Chen W, Wahl SM, Swaim W, Engelholm LH, Behrendt N, Bugge TH. 2002. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21: 3765-3779.
16. Lopez-Otin C, Matrisian LM. 2007. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7: 800-808.
17. Marino G, Uria JA, Puente XS, Quesada V, Bordallo J, Lopez-Otin C. 2003. Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J Biol Chem 278: 3671-3678.
18. Mohamed MM, Sloane BF. 2006. Cysteine cathepsins: Multifunctional enzymes in cancer. Nat Rev Cancer 6: 764-775.
19. Oberle C, Huai J, Reinheckel T, Tacke M, Rassner M, Ekert PG, Buellesbach J, Borner C. 2010. Lysosomal membrane permeabilization and cathepsin release is a Bax/Bak-dependent, amplifying event of apoptosis in fibroblasts and monocytes. Cell Death Differ 17: 1167-1178.
20. Pop C, Salvesen GS. 2009. Human caspases: Activation, specificity, and regulation. J Biol Chem 284: 21777-21781.
21. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. 2003. Human and mouse proteases: A comparative genomic approach. Nat Rev Genet 4: 544-558.
22. Rodriguez D, Morrison CJ, Overall CM. 2010. Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta 1803: 39-54.
23. Sevenich L, Schurigt U, Sachse K, Gajda M, Werner F, Muller S, Vasiljeva O, Schwinde A, Klemm N, Deussing J, et al. 2010. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci 107: 2497-2502.
24. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z. 1999. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98: 137-146.
25. Vasiljeva O, Turk B. 2008. Dual contrasting roles of cysteine cathepsins in cancer progression: Apoptosis versus tumour invasion. Biochimie 90: 380-386.
26. Vasiljeva O, Korovin M, Gajda M, Brodoefel H, Bojic L, Kruger A, Schurigt U, Sevenich L, Turk B, Peters C, et al. 2008. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene 27: 4191-4199.